Traitement pharmacologique dans le syndrome de Rett - Des résultats prometteurs chez la souris

Jean-Christophe Roux; Laurent Villard

doi:10.1051/medsci/20072310805

Accueil

Tous les numéros

Volume 23 / Numéro 10 (Octobre 2007)

Med Sci (Paris), 23 10 (2007) 805-807

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 23, Numéro 10, Octobre 2007


Page(s)		805 - 807
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20072310805
Publié en ligne		15 octobre 2007

Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr 1995; 84 : 971–6. [Google Scholar]
Moretti P, Zoghbi HY. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 2006; 16 : 276–81. [Google Scholar]
Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein2. Nat Genet 1999; 23 : 185–8. [Google Scholar]
Kerr AM, Armstrong DD, Prescott RJ, et al. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997; 6 (suppl 1) : 71–4. [Google Scholar]
Guy J, Hendrich B, Holmes M, et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001; 27 : 322–6. [Google Scholar]
Viemari JC, Roux JC, Tryba AK, et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 2005; 25 : 11521–30. [Google Scholar]
Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci 2003; 26 : 239–66. [Google Scholar]
Roux JC, Dura E, Moncla A, et al. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci 2007; 25 : 1915–22. [Google Scholar]
Nomura Y. Neurophysiology of Rett syndrome. Brain Dev 2001; 23 : S50–7. [Google Scholar]
Saito Y, Ito M, Ozawa Y, et al. Reduced expression of neuropeptides can be related to respiratory disturbances in Rett syndrome. Brain Dev 2001; 23 : S122–6. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr 1995; 84 : 971–6. [Google Scholar]

[2] Moretti P, Zoghbi HY. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 2006; 16 : 276–81. [Google Scholar]

[3] Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein2. Nat Genet 1999; 23 : 185–8. [Google Scholar]

[4] Kerr AM, Armstrong DD, Prescott RJ, et al. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997; 6 (suppl 1) : 71–4. [Google Scholar]

[5] Guy J, Hendrich B, Holmes M, et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001; 27 : 322–6. [Google Scholar]

[6] Viemari JC, Roux JC, Tryba AK, et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 2005; 25 : 11521–30. [Google Scholar]

[7] Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci 2003; 26 : 239–66. [Google Scholar]

[8] Roux JC, Dura E, Moncla A, et al. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci 2007; 25 : 1915–22. [Google Scholar]

[9] Nomura Y. Neurophysiology of Rett syndrome. Brain Dev 2001; 23 : S50–7. [Google Scholar]

[10] Saito Y, Ito M, Ozawa Y, et al. Reduced expression of neuropeptides can be related to respiratory disturbances in Rett syndrome. Brain Dev 2001; 23 : S122–6. [Google Scholar]